{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T19:32:23Z","timestamp":1771356743319,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,12,30]],"date-time":"2015-12-30T00:00:00Z","timestamp":1451433600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"This study was funded by Archimedes UK Pharma Ltd, the manufacturer of Pabrinex\u00ae."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Health Econ Health Policy"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s40258-015-0214-1","type":"journal-article","created":{"date-parts":[[2015,12,30]],"date-time":"2015-12-30T09:25:00Z","timestamp":1451467500000},"page":"205-215","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The Long-Term Cost to the UK NHS and Social Services of Different Durations of IV Thiamine (Vitamin B1) for Chronic Alcohol Misusers with Symptoms of Wernicke\u2019s Encephalopathy Presenting at the Emergency Department"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8369-1577","authenticated-orcid":false,"given":"Edward C. F.","family":"Wilson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Stanley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zulfiquar","family":"Mirza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,30]]},"reference":[{"key":"214_CR1","doi-asserted-by":"crossref","unstructured":"Thomson AD, Cook CCH, Touquet R, Henry JA. The Royal College of physicians report on alcohol: Guidelines for managing Wernicke\u2019s encephalopathy in the accident and emergency department. Alcohol Alcohol. 2002;37(6):513\u201321 (PubMed PMID: 2002430132. English).","DOI":"10.1093\/alcalc\/37.6.513"},{"key":"214_CR2","doi-asserted-by":"crossref","unstructured":"Harper C, Fornes P, Duyckaerts C, Lecomte D, Hauw JJ. An international perspective on the prevalence of the Wernicke\u2013Korsakoff syndrome. Metabolic brain disease. 1995;10(1):17\u201324 (PubMed PMID: 7596325. Epub 1995\/03\/01. Eng).","DOI":"10.1007\/BF01991779"},{"key":"214_CR3","doi-asserted-by":"crossref","unstructured":"Harper C, Gold J, Rodriguez M, Perdices M. The prevalence of the Wernicke-Korsakoff syndrome in Sydney, Australia: a prospective necropsy study. J Neurol Neurosurg Psychiatry. 1989;52(2):282\u20135 (PubMed PMID: 2784828. Pubmed Central PMCID: PMC1032524. Epub 1989\/02\/01. Eng).","DOI":"10.1136\/jnnp.52.2.282"},{"key":"214_CR4","doi-asserted-by":"crossref","unstructured":"Harper CG, Sheedy DL, Lara AI, Garrick TM, Hilton JM, Raisanen J. Prevalence of Wernicke\u2013Korsakoff syndrome in Australia: has thiamine fortification made a difference? Med J Aust. 1998;168(11):542\u20135 (PubMed PMID: 9640303. Pubmed Central PMCID: Pmc3391549. Epub 1998\/06\/26. Eng).","DOI":"10.5694\/j.1326-5377.1998.tb139081.x"},{"key":"214_CR5","doi-asserted-by":"crossref","unstructured":"Skullerud K, Andersen SN, Lundevall J. Cerebral lesions and causes of death in male alcoholics. A forensic autopsy study. Int J Legal Med. 1991;104(4):209\u201313 (PubMed PMID: 1931737. Epub 1991\/01\/01. Eng).","DOI":"10.1007\/BF01369809"},{"key":"214_CR6","doi-asserted-by":"crossref","unstructured":"Cook CC, Hallwood PM, Thomson AD. B Vitamin deficiency and neuropsychiatric syndromes in alcohol misuse. Alcohol Alcohol (Oxf, Oxfs). 1998;33(4):317\u201336 (PubMed PMID: 9719389).","DOI":"10.1093\/oxfordjournals.alcalc.a008400"},{"key":"214_CR7","doi-asserted-by":"crossref","unstructured":"Cook CC. Prevention and treatment of Wernicke-Korsakoff syndrome. Alcohol Alcohol (Oxf, Oxfs) Suppl. 2000;35(1):19\u201320 (PubMed PMID: 11304070. Epub 2001\/04\/17. Eng).","DOI":"10.1093\/alcalc\/35.Supplement_1.19"},{"key":"214_CR8","doi-asserted-by":"crossref","unstructured":"Kopelman MD, Thomson AD, Guerrini I, Marshall EJ. The Korsakoff syndrome: clinical aspects, psychology and treatment. Alcohol Alcohol (Oxf, Oxfs). 2009;44(2):148\u201354 (PubMed PMID: 19151162. Epub 2009\/01\/20. Eng).","DOI":"10.1093\/alcalc\/agn118"},{"key":"214_CR9","doi-asserted-by":"crossref","unstructured":"Sechi G, Serra A. Wernicke\u2019s encephalopathy: new clinical settings and recent advances in diagnosis and management. Lancet Neurol. 2007;6(5):442\u201355 (PubMed PMID: 17434099. Epub 2007\/04\/17. Eng).","DOI":"10.1016\/S1474-4422(07)70104-7"},{"key":"214_CR10","doi-asserted-by":"crossref","unstructured":"Thomson AD, Guerrini I, Marshall EJ. The evolution and treatment of Korsakoff\u2019s syndrome: out of sight, out of mind? Neuropsychol Rev. 2012;22(2):81\u201392 (PubMed PMID: 22569770. Pubmed Central PMCID: PMC3545191. Epub 2012\/05\/10. Eng).","DOI":"10.1007\/s11065-012-9196-z"},{"key":"214_CR11","doi-asserted-by":"crossref","unstructured":"Thomson AD, Cook CCH, Guerrini I, Sheedy D, Harper C, Marshall EJ. Wernicke\u2019s encephalopathy: \u2018Plus ca change, plus c\u2019est la meme chose\u2019. Alcohol Alcohol. 2008;43(2):180\u20136 (PubMed PMID: 2008166133. English).","DOI":"10.1093\/alcalc\/agm149"},{"key":"214_CR12","volume-title":"ABC of alcohol","author":"A Paton","year":"2005","unstructured":"Paton A, Touquet R. ABC of alcohol. 4th ed. Malden: Blackwell Publishing; 2005.","edition":"4"},{"key":"214_CR13","doi-asserted-by":"crossref","unstructured":"Harper CG, Giles M, Finlay-Jones R. Clinical signs in the Wernicke-Korsakoff complex: a retrospective analysis of 131 cases diagnosed at necropsy. J Neurol Neurosurg Psychiatry. 1986;49(4):341\u20135 (PubMed PMID: 3701343. Pubmed Central PMCID: 1028756. Epub 1986\/04\/01. Eng).","DOI":"10.1136\/jnnp.49.4.341"},{"key":"214_CR14","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1136\/pgmj.67.793.978","volume":"67","author":"DP Naidoo","year":"1991","unstructured":"Naidoo DP, Bramdev A, Cooper K. Wernicke\u2019s encephalopathy and alcohol-related disease. Postgrad Med J. 1991;67:978\u201381.","journal-title":"Postgrad Med J."},{"key":"214_CR15","doi-asserted-by":"crossref","unstructured":"Touquet R, Brown A. Alcohol misuse: positive response. Alcohol Health Work for every acute hospital saves money and reduces repeat attendances. EMA\u2014Emergency Medicine Australasia. 2006;18(2):103\u20137 (PubMed PMID: 2006170524. English).","DOI":"10.1111\/j.1742-6723.2006.00834.x"},{"key":"214_CR16","unstructured":"Victor M, Adams RD, Collins GH. The Wernicke\u2013Korsakoff syndrome and related neurologic disorders due to alcoholism and malnutrition. 2nd ed. Philadelphia: F.A. Davis Co.; 1989."},{"key":"214_CR17","doi-asserted-by":"crossref","unstructured":"Agro K, Blackhouse G, Goeree R, Willan AR, Huang JQ, Hunt RH, et al. Cost effectiveness in Canada of a multidrug prepackaged regimen (Hp-PAC)+ for Helicobacter pylori eradication. Pharmacoeconomics. 2001;19(8):831\u201343 (PubMed PMID: 11596835. Epub 2001\/10\/13. Eng).","DOI":"10.2165\/00019053-200119080-00005"},{"key":"214_CR18","unstructured":"Joint Formulary Committee. British National Formulary. 67th ed. London: BMJ Group and Pharmaceutical Press; 2014."},{"key":"214_CR19","volume-title":"Alcohol-use disorders: diagnosis and clinical management of alcohol-related physical complications","author":"National Institute for Health and Care Excellence","year":"2010","unstructured":"National Institute for Health and Care Excellence. Alcohol-use disorders: diagnosis and clinical management of alcohol-related physical complications. London: NICE; 2010."},{"key":"214_CR20","unstructured":"Amato L, Davoli M, Ali R, F. F, Farrell M, Foxcroft D, Cochrane Drugs and Alcohol Group, et al. About the Cochrane Collaboration (Cochrane Review Groups (CRGs) 2014, Issue 10 [10 November 2014]). Available from: http:\/\/onlinelibrary.wiley.com\/o\/cochrane\/clabout\/articles\/ADDICTN\/frame.html . Last accessed 7 Nov 2015."},{"key":"214_CR21","doi-asserted-by":"crossref","unstructured":"Day E, Bentham PW, Callaghan R, Kuruvilla T, George S. Thiamine for prevention and treatment of Wernicke-Korsakoff Syndrome in people who abuse alcohol. Cochrane Database Syst Rev. 2013;7:CD004033 (PubMed PMID: 23818100. Epub 2013\/07\/03. Eng).","DOI":"10.1002\/14651858.CD004033.pub3"},{"issue":"1","key":"214_CR22","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1530-0277.2001.tb02134.x","volume":"25","author":"ML Ambrose","year":"2001","unstructured":"Ambrose ML, Bowden SC, Whelan G. Thiamin treatment and working memory function of alcohol-dependent people: preliminary findings. Alcohol Clin Exp Res. 2001;25(1):112\u20136.","journal-title":"Alcohol Clin Exp Res."},{"key":"214_CR23","doi-asserted-by":"crossref","unstructured":"Oakley JE, O\u2019Hagan A. SHELF: The Sheffield Elicitation Framework (version 2.0) Sheffield, UK2010. 2014. Available from: http:\/\/tonyohagan.co.uk\/shelf . Last accessed 7 Nov 2015","DOI":"10.32614\/CRAN.package.SHELF"},{"key":"214_CR24","unstructured":"Benaouda F. The prophylactic use of Pabrinex during alcohol detoxification treatment. Clinical Pharmacist. 2011;3(3):S2 (PubMed PMID: 70749560. English)."},{"key":"214_CR25","doi-asserted-by":"crossref","unstructured":"Ferguson RK, Soryal IN, Pentland B. Wernicke-Korsakoff syndrome in head injury: a missed insult. Alcohol and alcoholism (Oxford, Oxfordshire) Supplement. 2000;35(1):16\u20138 (PubMed PMID: 11304069. Epub 2001\/04\/17. Eng).","DOI":"10.1093\/alcalc\/35.Supplement_1.16"},{"key":"214_CR26","doi-asserted-by":"crossref","unstructured":"Isenberg-Grzeda E, Chabon B, Nicolson SE. Prescribing thiamine to inpatients with alcohol use disorders: how well are we doing? Journal of addiction medicine. 2014;8(1):1\u20135 (PubMed PMID: 24343128. Epub 2013\/12\/18. Eng).","DOI":"10.1097\/01.ADM.0000435320.72857.c8"},{"key":"214_CR27","doi-asserted-by":"crossref","unstructured":"Thomson AD, Cook CC. Parenteral thiamine and Wernicke\u2019s encephalopathy: the balance of risks and perception of concern. Alcohol Alcohol (Oxf, Oxfs). 1997;32(3):207\u20139 (PubMed PMID: 9199720. Epub 1997\/05\/01. Eng).","DOI":"10.1093\/oxfordjournals.alcalc.a008259"},{"key":"214_CR28","doi-asserted-by":"crossref","unstructured":"Ferguson RK, Soryal IN, Pentland B. Thiamine deficiency in head injury: a missed insult? Alcohol Alcohol (Oxf, Oxfs). 1997;32(4):493\u2013500 (PubMed PMID: 9269857. Epub 1997\/07\/01. Eng).","DOI":"10.1093\/oxfordjournals.alcalc.a008284"},{"key":"214_CR29","doi-asserted-by":"crossref","unstructured":"Hope LC, Cook CC, Thomson AD. A survey of the current clinical practice of psychiatrists and accident and emergency specialists in the United Kingdom concerning vitamin supplementation for chronic alcohol misusers. Alcohol Alcohol (Oxf, Oxfs). 1999;34(6):862\u20137 (PubMed PMID: 10659721).","DOI":"10.1093\/alcalc\/34.6.862"},{"key":"214_CR30","unstructured":"Office for National Statistics. Interim Life tables for England 1980-82 to 2010-12. Webpage. http:\/\/www.ons.gov.uk\/ons\/rel\/lifetables\/interim-life-tables\/2010-2012\/rft-england.xls . Last accessed 7 Nov 2015."},{"key":"214_CR31","doi-asserted-by":"crossref","unstructured":"Rehm J, Greenfield TK, Rogers JD. Average volume of alcohol consumption, patterns of drinking, and all-cause mortality: results from the US National Alcohol Survey. Am J Epidemiol. 2001;153(1):64\u201371.","DOI":"10.1093\/aje\/153.1.64"},{"key":"214_CR32","volume-title":"The 2004 national alcohol needs assessment for England","author":"C Drummond","year":"2004","unstructured":"Drummond C, Oyefeso A, Phillips T, Cheeta S, Deluca P, Perryman K, et al. The 2004 national alcohol needs assessment for England. London: Department of Health; 2004."},{"key":"214_CR33","doi-asserted-by":"crossref","unstructured":"Pharoah PD, Hollingworth W. Cost effectiveness of lowering cholesterol concentration with statins in patients with and without pre-existing coronary heart disease: life table method applied to health authority population. BMJ. 1996;312(7044):1443\u20138 (PubMed PMID: 8664620. Pubmed Central PMCID: 2351181).","DOI":"10.1136\/bmj.312.7044.1443"},{"key":"214_CR34","unstructured":"Gray A, Clarke P, Wolstenholme J, Wordsworth S. Applied methods of cost-effectiveness analysis in health care. In: Gray A, Briggs A, editors. Oxford: Oxford University Press; 2011."},{"key":"214_CR35","doi-asserted-by":"crossref","unstructured":"Pirmohamed M, Brown C, Owens L, Luke C, Gilmore IT, Breckenridge AM, et al. The burden of alcohol misuse on an inner\u2010city general hospital. QJM. 2000;93(5):291\u20135.","DOI":"10.1093\/qjmed\/93.5.291"},{"key":"214_CR36","volume-title":"Unit Costs of Health and Social Care 2013","author":"L Curtis","year":"2014","unstructured":"Curtis L. Unit Costs of Health and Social Care 2013. Canterbury: University of Kent at Canterbury; 2014."},{"key":"214_CR37","unstructured":"Department of Health. National Schedule of Reference Costs 2012-13. London. https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/260405\/2012-13_national_schedule_of_reference_costs.xls . Last accessed 7 Nov 2015."},{"key":"214_CR38","volume-title":"The green book: appraisal and evaluation in Central Government","author":"HM Treasury","year":"2003","unstructured":"Treasury HM. The green book: appraisal and evaluation in Central Government. London: HM Treasury; 2003."},{"key":"214_CR39","unstructured":"National Institute for Health and Care Excellence. Guide to the Methods of Technology Appraisal 2013. London. http:\/\/www.nice.org.uk\/article\/pmg9\/chapter\/Foreword . Last accessed: 7 Nov 2015."},{"key":"214_CR40","unstructured":"Metvix 160\u00a0mg\/g cream summary of product characteristics 2007. Available from: http:\/\/emc.medicines.org.uk\/emc\/assets\/c\/html\/DisplayDoc.asp?DocumentID=11913 . Cited 30 Oct 2007."},{"key":"214_CR41","volume-title":"A new settlement for health and social care","author":"The King\u2019s Fund","year":"2014","unstructured":"The King\u2019s Fund. A new settlement for health and social care. London: The King\u2019s Fund; 2014."},{"key":"214_CR42","unstructured":"Cabinet Office Strategy Unit. Alcohol misuse: how much does it cost? London: HMSO (Her Majesty's Stationery Office); 2003."}],"container-title":["Applied Health Economics and Health Policy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-015-0214-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40258-015-0214-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-015-0214-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T23:43:56Z","timestamp":1748735036000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40258-015-0214-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,30]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["214"],"URL":"https:\/\/doi.org\/10.1007\/s40258-015-0214-1","relation":{},"ISSN":["1175-5652","1179-1896"],"issn-type":[{"value":"1175-5652","type":"print"},{"value":"1179-1896","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,30]]}}}